Viewing Study NCT06559150


Ignite Creation Date: 2025-12-24 @ 4:52 PM
Ignite Modification Date: 2025-12-28 @ 5:21 PM
Study NCT ID: NCT06559150
Status: RECRUITING
Last Update Posted: 2025-10-28
First Post: 2024-08-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
Sponsor: Verona Pharma plc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module